Role of gut luminal microplastics in Ulcerative Colitis physiopathology – UCplastic
Ulcerative colitis (UC) is a chronic inflammatory bowel disease caused by genetic and environmental factors. The latter act firstly as neonatal primers: their exposure during the perinatal period disturbs early maturation of gut microbiota and immune system and induces an increased susceptibility to colitis, called pathological imprinting. Environmental factors act secondly as colitis triggers, causing or worsening colitis development in patients with genetic susceptibility or pathological imprinting. Our hypothesis is that gut luminal microplastics (MPs), which are increasingly present because of expanding human oral MP exposure, belong to environmental UC primers and/or triggers. Indeed, pilot studies detected MPs in neonatal and adult feces, and accumulating data show that ingestion of MPs promote gut inflammation and dysbiosis in mice. Our main aims are:1) To identify in human feces the MPs with pro-inflammatory and pro-dysbiotic properties. Nano-and microplastics will be characterized in control and UC patient feces and correlated with inflammatory calprotectin level and dysbiosis parameters. Combined analyzes will identify a cocktail of MPs with pro-inflammatory and pro-dysbiotic properties thereafter called pro-UC MP cocktail. 2) To assess MP effects on UC pathogenesis either as neonatal primer of UC susceptibility and/or as promoting UC trigger. Pregnant mice will be exposed to the pro-UC MP cocktail and the effects on gut immune response, permeability, microbiota, nano-and microplastic presence in feces, and susceptibility to experimental colitis will be assessed in male and female offspring. These parameters as well as fecal metabolome will be also assessed in response to the pro-UC MP cocktail exposure in gnotobiotic mice colonized with humanized microbiota from control or UC patients. This multidisciplinary project will provide new essential knowledge on human exposure to MPs and their impact on gut homeostasis, particularly in the UC pathophysiology.
Project coordination
Mathilde Body-Malapel (Institute for Translational Research in Inflammation)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partnership
DRI Direction de la Recherche et de l'Innovation
IPREM INSTITUT DES SCIENCES ANALYTIQUES ET DE PHYSICO-CHIMIE POUR L'ENVIRONNEMENT ET LES MATERIAUX
INFINITE Institute for Translational Research in Inflammation
ANSES Laboratoire de Fougères
ANSES-LSAl ANSES - Laboratoire de sécurité des aliments, sites de Maisons-Alfort et de Boulogne-sur-Mer
CHU Lille Centre Hospitalier Universitaire de Lille
Help of the ANR 570,396 euros
Beginning and duration of the scientific project:
September 2022
- 42 Months